- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
International Journal of Endocrinology
Volume 2013 (2013), Article ID 578693, 6 pages
Elevated Serum Gamma-Glutamyltransferase Is a Strong Marker of Insulin Resistance in Obese Children
1Department of Family Medicine, Inje University, College of Medicine, Sanggyepaik Hospital, Nowon-Gu, Seoul 139-707, Republic of Korea
2Department of Family Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University, School of Medicine, 108 Pyongdong, Jongro-Gu, Seoul 110-746, Republic of Korea
3Department of Occupational Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University, School of Medicine, 108 Pyongdong, Jongro-Gu, Seoul 110-746, Republic of Korea
4Health Screening Center, Kangbuk Samsung Hospital, Sungkyunkwan University, School of Medicine, Seoul 110-746, Republic of Korea
Received 22 October 2012; Revised 29 January 2013; Accepted 15 February 2013
Academic Editor: Barry Posner
Copyright © 2013 Seon Yeong Lee et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- C. A. Fagot and K. Narayan, “Type 2 diabetes in children,” British Medical Journal, vol. 322, pp. 377–387, 2001.
- C. Levy-Marchal, S. Arslanian, W. Cutfield et al., “Insulin resistance in children: consensus, perspective, and future directions,” Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 12, pp. 5189–5198, 2010.
- J. M. Clark, F. L. Brancati, and A. M. Diehl, “The prevalence and etiology of elevated aminotransferase levels in the United States,” American Journal of Gastroenterology, vol. 98, no. 5, pp. 960–967, 2003.
- R. S. Strauss, S. E. Barlow, and W. H. Dietz, “Prevalence of abnormal serum aminotransferase values in overweight and obese adolescents,” Journal of Pediatrics, vol. 136, no. 6, pp. 727–733, 2000.
- A. O. Rantala, M. Lilja, H. Kauma, M. J. Savolainen, A. Reunanen, and Y. A. Kesäniemi, “Gamma-glutamyl transpeptidase and the metabolic syndrome,” Journal of Internal Medicine, vol. 248, no. 3, pp. 230–238, 2000.
- I. J. Perry, S. G. Wannamethee, and A. G. Shaper, “Prospective study of serum γ-glutamyltransferase and risk of NIDDM,” Diabetes Care, vol. 21, no. 5, pp. 732–737, 1998.
- D. H. Lee, D. R. Jacobs, M. Gross et al., “γ-glutamyltransferase is a predictor of incident diabetes and hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) study,” Clinical Chemistry, vol. 49, no. 8, pp. 1358–1366, 2003.
- B. Vozarova, N. Stefan, R. S. Lindsay et al., “High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes,” Diabetes, vol. 51, no. 6, pp. 1889–1895, 2001.
- A. J. G. Hanley, K. Williams, A. Festa et al., “Elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis study,” Diabetes, vol. 53, no. 10, pp. 2623–2632, 2004.
- M. Nannipieri, C. Gonzales, S. Baldi et al., “Liver enzymes, the metabolic syndrome, and incident diabetes: the Mexico City diabetes study,” Diabetes Care, vol. 28, no. 7, pp. 1757–1762, 2005.
- R. K. Schindhelm, M. Diamant, J. M. Dekker, M. E. Tushuizen, T. Teerlink, and R. J. Heine, “Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease,” Diabetes/Metabolism Research and Reviews, vol. 22, no. 6, pp. 437–443, 2006.
- Y. Chang, S. Ryu, E. Sung, and Y. Jang, “Higher concentrations of alanine aminotransferase within the reference interval predict nonalcoholic fatty liver disease,” Clinical Chemistry, vol. 53, no. 4, pp. 686–692, 2007.
- R. M. O'Brien and D. K. Granner, “Regulation of gene expression by insulin,” Biochemical Journal, vol. 278, pp. 609–619, 1991.
- E. Nemesanszky and J. A. Lott, “Gamma-glutamyltransferase and its isoenzymes: progress and problems,” Clinical Chemistry, vol. 31, no. 6, pp. 797–803, 1985.
- D. R. Karp, K. Shimooku, and P. E. Lipsky, “Expression of γ-glutamyl transpeptidase protects ramos B cells from oxidation-induced cell death,” The Journal of Biological Chemistry, vol. 276, no. 6, pp. 3798–3804, 2001.
- M. H. Hanigan and W. A. Ricketts, “Extracellular glutathione is a source of cysteine for cells that express γ-glutamyl transpeptidase,” Biochemistry, vol. 32, no. 24, pp. 6302–6306, 1993.
- The Korean Pediatric Society Health Statistics Committee, Standard Data Regarding Physical Development of Korean Children and Teenages, The Korean Pediatric Society, Seoul, Republic of Korea, 1999.
- B. K. Cho, J. H. Kang, J. S. Lee, and B. Y. Yu, “The usefulness of inbody 720 and anthropometric measurement compared with dual-energy x-ray absorptiometry as a diagnostic tool of childhood obesity,” Journal of the Korean Academy of Family Medicine, vol. 28, pp. 523–531, 2007.
- Y. Copieters and F. Parent, “Blood pressure measurement in epidemiological investigation in teenagers,” European Journal of Epidemiology, vol. 17, no. 10, pp. 901–906, 2001.
- D. R. Matthews, J. P. Hosker, A. S. Rudenski, B. A. Naylor, D. F. Treacher, and R. C. Turner, “Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man,” Diabetologia, vol. 28, no. 7, pp. 412–419, 1985.
- E. Ortega, J. Koska, A. D. Salbe, P. A. Tataranni, and J. C. Bunt, “Serum γ-glutamyl transpeptidase is a determinant of insulin resistance independently of adiposity in Pima Indian children,” Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 4, pp. 1419–1422, 2006.
- W. C. Knowler, P. H. Bennett, R. F. Hammam, and M. Miller, “Diabetes incidence and prevalence in Pima Indians: a 19-fold greater incidence than in Rochester, Minnesota,” American Journal of Epidemiology, vol. 108, no. 6, pp. 497–505, 1979.
- L. J. Baier and R. L. Hanson, “Genetic studies of the etiology of type 2 diabetes in Pima Indians: hunting for pieces to a complicated puzzle,” Diabetes, vol. 53, no. 5, pp. 1181–1186, 2004.
- M. I. Goran and B. A. Gower, “Longitudinal study on pubertal insulin resistance,” Diabetes, vol. 50, no. 7–12, pp. 2444–2450, 2001.
- J. B. Whitfield, “Gamma-glutamyltransferase,” Critical Reviews in Clinical Laboratory Sciences, vol. 38, pp. 263–3553, 2001.
- O. Nilssen, O. H. Forde, and T. Brenn, “The Tromso study: distribution and population determinants of gamma-glutamyltransferase,” American Journal of Epidemiology, vol. 132, no. 2, pp. 318–326, 1990.
- A. Paolicchi, M. Emdin, E. Ghliozeni et al., “Human atherosclerotic plaques contain gamma-glutamyl transpeptidase enzyme activity,” Circulation, vol. 109, no. 11, article 1440, 2004.
- D. H. Lee and D. R. Jacobs Jr., “Association between serum gamma-glutamyltransferase and C-reactive protein,” Atherosclerosis, vol. 178, no. 2, pp. 327–330, 2005.
- J. Yamada, H. Tomiyama, M. Yambe et al., “Elevated serum levels of alanine aminotransferase and gamma glutamyltransferase are markers of inflammation and oxidative stress independent of the metabolic syndrome,” Atherosclerosis, vol. 189, no. 1, pp. 198–205, 2006.
- M. D. Michael, R. N. Kulkarni, C. Postic et al., “Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction,” Molecular Cell, vol. 6, no. 1, pp. 87–97, 2000.
- J. B. Schwimmer, R. Deutsch, J. B. Rauch, C. Behling, R. Newbury, and J. E. Lavine, “Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease,” Journal of Pediatrics, vol. 143, no. 4, pp. 500–505, 2003.
- G. Marchesini, M. Brizi, G. Blanchi et al., “Nonalcoholic fatty liver disease: a feature of the metabolic syndrome,” Diabetes, vol. 50, no. 8, pp. 1844–1850, 2001.
- D. A. Patel, S. R. Srinivasan, J. H. Xu, W. Chen, and G. S. Berenson, “Persistent elevation of liver function enzymes within the reference range is associated with increased cardiovascular risk in young adults: the Bogalusa Heart study,” Metabolism, vol. 56, no. 6, pp. 792–798, 2007.
- Y. H. Kang, H. K. Min, S. M. Son, I. J. Kim, and Y. K. Kim, “The association of serum gamma glutamyltransferase with components of the metabolic syndrome in the Korean adults,” Diabetes Research and Clinical Practice, vol. 77, no. 2, pp. 306–313, 2007.
- A. R. Sinaiko, J. Steinberger, A. Moran et al., “Relation of body mass index and insulin resistance to cardiovascular risk factors, inflammatory factors, and oxidative stress during adolescence,” Circulation, vol. 111, no. 15, pp. 1985–1991, 2005.
- J. Steinberger, C. Moorehead, V. Katch, and A. P. Rocchini, “Relationship between insulin resistance and abnormal lipid profile in obese adolescents,” Journal of Pediatrics, vol. 126, no. 5 I, pp. 690–695, 1995.